Medicine composition for preventing and treating arthritis and application thereof

A composition and technology for arthritis, applied in the application field of medicine or health care products, can solve the problems of low immunity, long course of treatment, single curative effect of arthritis, etc.

Active Publication Date: 2013-12-18
庞会心
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no specific drug for the treatment of arthritis in Western medicine, and the conventional medication is mainly hormone drugs, and its therapeutic purpose is usually temporary pain relief
In addition, long-term use of hormone drugs can cause central obesity (buffalo back, full moon face), osteoporosis, low immunity...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for preventing and treating arthritis and application thereof
  • Medicine composition for preventing and treating arthritis and application thereof
  • Medicine composition for preventing and treating arthritis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] 1. Weigh 110g of glucosamine hydrochloride, 135g of biological calcium carbonate, 30g of Rhizoma Drynariae extract, 4.5g of casein phosphopeptide, 70g of chondroitin sulfate, and 46.5g of Epimedium extract, and pass through a 80-mesh sieve , qualified spare.

[0073] 2. Mix the substances described in step 1 uniformly to obtain the pharmaceutical composition of the present invention.

Embodiment 2

[0075] 1. Weigh 85g of glucosamine hydrochloride, 100g of biological calcium carbonate, 60g of Rhizoma drynaria extract, 5g of casein phosphopeptide, 45g of chondroitin sulfate, and 100g of Epimedium extract for bacterial inspection, pass through a 80-mesh sieve, and pass the test spare.

[0076] 2. Mix the substances described in step 1 uniformly to obtain the pharmaceutical composition of the present invention.

Embodiment 3

[0078] 1. Bacterial inspection of 90g of glucosamine hydrochloride, 115g of biological calcium carbonate, 50g of drynaria extract, 6g of casein phosphopeptide, 54g of chondroitin sulfate, and 80g of epimedium extract, passed through a 80-mesh sieve, qualified for future use .

[0079] 2. Mix the substances described in step 1 uniformly to obtain the pharmaceutical composition of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicine composition for preventing and treating arthritis. The medicine composition comprises the following components in percentage by weight: 15%-35% of glucosamine hydrochloride, 20%-40% of biological calcium carbonate, 5%-20% of rhizoma drynariae extract, 1%-5% of casein phosphopeptides, 10%-20% of chondroitin sulfate and 10%-30% of epimedium extract. The medicine composition has the advantages of being capable of obviously inhibiting inflammatory cell factors in serum and joint fluid of arthritics patients, relieving the symptoms and signs of the patients, adjusting the immunologic functions of the patients, and effectively preventing and treating diseases such as rheumatism, rheumatoid arthritis, osteoarthritis and gouty arthritis. The invention also provides an application of the medicine composition in the preparation of medicines for preventing and treating diseases such as the rheumatism, the rheumatoid arthritis, the osteoarthritis and the gouty arthritis.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition capable of preventing and treating arthritis, and its application in the preparation of medicines or health products for preventing and treating arthritis. Background technique [0002] Arthritis refers to arthritic lesions caused by inflammation, infection, trauma or other factors. It is an autoimmune disease and is a common disease in middle-aged and elderly people. The disease is characterized by persistent synovitis, manifested by synovial thickening, increased synovial fluid, angiogenesis, and inflammatory cell infiltration, which in turn invade cartilage and bone tissue, resulting in joint damage. Among them, a large number of oxygen free radicals produced by phagocytes play an important role in the occurrence and development of arthritis. [0003] At present, there is no specific drug for the treatment of arthritis in Western medicine. The conve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/17A23L1/29A61P19/02A61P29/00A61P19/06A61K36/296A61K36/11A61K33/10A61K31/737A61K31/7008A23L33/00
Inventor 庞会心
Owner 庞会心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products